Country CodeNCIt concept

https://www.inrs.fr/media.html?refINRS=NO%2042
2024
France
journal article
organ part
Safety
Normalize
CDISC SDTM Body Position Terminology
Position
Country Code
Job Security
occupation, nos
adoption
standardization
adoption, nos
Occupational Health
safety, occupational
Adopted Son
Netherlands
CDISC SEND Country Terminology
Gene Physical Location
organizations
Safety Study
reference standards
Health Communication
occupational health
health communication
Organisms Category
Million Organisms
Organism

---
https://iris.who.int/handle/10665/373065
2023
Switzerland
journal article
Epidemic Disorder
Country Code
meningitis
meningococcal meningitis
Meningitis
belt, nos
epidemics
Belt Device
wrestling
Netherlands
CDISC SEND Country Terminology

---
https://www.irdes.fr/documentation/syntheses/les-assistants-medicaux-en-france-et-dans-les-pays-de-l-ocde.pdf
2023
France
bibliography
medical assistant
Netherlands
Medical Assistant
Organisation for Economic Co-Operation and Development
counseling
medical assistance
french
CHFR Gene
Country Code
CDISC SEND Country Terminology
france

---
https://www.cochrane.org/fr/CD014722/EPOC_interventions-des-travailleurs-communautaires-et-en-soins-de-sante-primaire-pour-la-prevention-des
2023
United Kingdom
review of literature
french abstract
primary health care
community health services
primary prevention
asthenia
Interim Study Report
Country Code
normal mental state
community health care
Care Of
Netherlands
Promotion
Antimicrobial Intermediate Susceptibility Result
Intermediate Mitosis-Karyorrhexis Index
income
mental disorder, nos
primary health care
IPSS-R Risk Category Intermediate
Disease or Disorder
promoter regions, genetic
community health workers
preventive medicine
Community Health
Primary Care
Primary Prevention
Important that I Look Good
Poverty
principal
CDISC SEND Country Terminology
International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Intermediate-Risk Group
mental disorders
Health Care Delivery

---
https://www.cochrane.org/fr/cd014785/behav_limpact-du-suivi-et-de-la-promotion-de-la-croissance-chez-les-enfants-de-moins-de-cinq-ans-dans-les
2023
United Kingdom
review of literature
french abstract
Follow
CDISC SEND Country Terminology
growth
Interim Study Report
Generalized Growth
Intermediate Mitosis-Karyorrhexis Index
IPSS-R Risk Category Intermediate
promoter regions, genetic
Country Code
income
International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Intermediate-Risk Group
aftercare
asthenia
Poverty
Every Five Years
Antimicrobial Intermediate Susceptibility Result
Offspring
Promotion
Growth
child
Netherlands
child, nos
Clinical Study Follow-up
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
Child
Impact

---
https://www.oecd-ilibrary.org/social-issues-migration-health/profils-sur-le-cancer-par-pays-france-2023_1dd7dd7f-fr;jsessionid=pQ5uYkR-c191So4VCBnQxjiqsQouiY6Ts9pm8xb0.ip-10-240-5-38
2023
France
technical report
Country Code
neoplasms
Profile
neoplasm, malignant
france
french
cancer
Netherlands
CDISC SEND Country Terminology
CHFR Gene
Malignant Neoplasm

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1352
2023
France
public health guidelines
waiting lists
morocco
Human Virus
human body
Add
Netherlands
Attention Deficit Hyperactivity Disorder, Inattentive Type
west nile virus
Corpus Uteri
gift giving
Supplies
Body of the Pancreas
West Nile Virus
Body of Stomach
Body
risk
CDISC SEND Country Terminology
Sequence Data Type
human virus, nos
Country Code

---
https://dumas.ccsd.cnrs.fr/dumas-04208921
2023
France
dissertations, academic
Violence
violence
primary health care
Scientific Equipment
Country Code
Last Screening
File Validated
Woman
Tool
Netherlands
Eligibility Determination
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
women
nursing
principal
Substance Screening
Tumor Identifier Evaluator Identifier
Cancer Screening
Going Well
screening
Primary Care
Validation
primary health care
Organisation for Economic Co-Operation and Development
Validation Batch
tool, nos
Trial Screening
Screening Study
Genetic Screening
CDISC SEND Country Terminology
mass screening
Site Screening

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-liees-au-travail/maladies-a-caractere-professionnel/documents/rapport-synthese/surveillance-des-maladies-a-caractere-professionnel-en-region-pays-de-la-loire-resultats-des-quinzaines-2020-2022
2023
France
journal article
Attention Concentration
CDISC SEND Country Terminology
Clinical Trial Registry Identifier
Disease or Disorder
Country Code
Professional Occupation
character
occupational diseases
Management
organization and administration
disease, nos
Netherlands
resulting in
Character Set
Health Care Professional Promotional Material

---
https://www.orspaysdelaloire.com/sites/default/files/pages/pdf/2023_PDF/2023_Guide_DLSE_PdL_Bretagne.pdf
2023
France
handbooks
Guide Device
Integrator Device
environmental policy
CDISC SEND Country Terminology
Locally
Health Policy
environmental health
Environmental
Integrated
Location of Oral Residue Following Swallowing
Diagnosis Study
Approximate
Local-Regional
Netherlands
residence characteristics
Location of Pharyngeal Residue Following Swallowing
Surrounding
Diagnosis Code
achievement
Disease or Disorder
diagnosis
Localized Disease
Country Code
Date of Diagnosis
Anatomic Site
health policy
Handbook
Brittany
no diagnosis

---
https://www.health.belgium.be/fr/avis-9754-ar-interdiction-dexportation-de-substances-dangereuses
2023
Belgium
technical report
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
No History of Non-Cardiac Surgery
Nitric Oxide Measurement
ERBB2 Mutation Analysis Was Not Performed
Negation
ATRX Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
Certain
Unemployed
No History of Neonatal Complication
Some
PTEN Mutation Analysis Was Not Performed
hazardous substances
Minor Criteria for Rheumatic Heart Disease Not Present
Chief Complaint Not Caused by Trauma
Extremity Part
Radiation Therapy Not Received
MGMT Promoter Methylation Testing Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
NRAS Mutation Analysis Was Not Performed
Version
Documentation Absent
Murine Limb
Projected
BRAF Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
CDISC SEND Country Terminology
ATRX Gene Mutation Negative
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Gestational Complication
10q23/PTEN Locus Deletion Analysis Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Paraneoplastic Syndrome is Not Present
Chief Complaint was Not Witnessed
Export
PTEN Gene Mutation Negative
Tumor Reoccurrence Absent After Initial Treatment
TP53 Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
No History of Congenital Heart Disease
Any Metastatic Diagnosis Absent
all extremities
First Degree Family History Cancer Negative
european union
Other Preoperative IV Medications were not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
History of Colorectal Cancer Negative
First Degree Family History of Primary Brain Tumor Negative
Caffeine Not Routinely Consumed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Projection
Adjuvant I-131 Therapy Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
ALK Rearrangement Analysis Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Substance
Medication Not Taken
Hypertension Absent
Chemotherapy Not Received
Evidence of Disease Absent after Completion of Therapy
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
SDH Complex Mutation Analysis Was Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Chemical/Occupational Exposure Absent
extremities
Cancer History Absent
EGFR Amplification Analysis Was Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No Response to Intervention for Kawasaki Disease
History of Medical Treatment Absent
KRAS Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
IDH Family Wildtype
No History of Kawasaki Disease
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Neither Case or Control Status
Routine Cytogenetics Were not Completed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
New Disease is not Multifocal
Nitric Oxide
No History of Myopathy
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Adverse Event Definitely Related to Intervention
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NON Mouse
Radiation History Negative
Preoperative IV Opiates were not Administered
MET Mutation Analysis Was Not Performed
Neither
Therapeutic Ionizing Radiation to Head History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
Additional Surgery for New Tumor Event Absent
No History of Rheumatic Fever
First Degree Family History Thyroid Cancer Negative
New Tumor Event After Initial Treatment Absent
Membership
Country Code
Another Form of Birth Control was not Used
No Known History of Alcohol Use
Regional Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Family History of Stomach Cancer Absent
Netherlands
1p/19q Deletion Analysis Was Not Performed
Has No Sibling
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Norway
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
NF1 Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Preoperative IV Sedation was Not Administered
ROS1 Rearrangement Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Tumor Progression Absent After Initial Treatment
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Physician Diagnosed Diabetes Absent
Preoperative IV Antacids were not Administered
EGFR Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Additional Molecular Studies Were Not Performed
Preoperative IV Antiemetics were not Administered
Discontinue
Adjuvant Post-operative Immunological Therapy Was Not Administered
European Union
EGFR Gene Amplification Negative
Additional Immunohistochemistry Was Not Performed
IDH Family Mutation Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No Known History of Illicit Drug Use

---
https://www.who.int/fr/publications-detail/9789240076488
2023
Switzerland
technical report
child
Netherlands
Human Immunodeficiency Virus
HIV
Validation
child, nos
Validation Batch
CDISC SEND Country Terminology
Disease Transmission
Country Code
mother, nos
Removed
infectious disease transmission, vertical
asthenia
Child Relation
acceleration
Child Individual
Feel Weak
Application Context
human immunodeficiency virus, nos

---
https://www.who.int/fr/publications-detail/9789290234449
2020
Switzerland
handbooks
Increment
wrestling
Regulatory Action
Treatment Step
Handbook
CDISC SEND Country Terminology
cancrum oris
government programs
Noma
Country Code
noma
Netherlands
Step
Stair
Guide Device
Step Unit of Distance

---